Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Europe
Almost one year after the US Supreme Court’s Halo decision, companies should consider a handful of best practices to reduce the risk of paying enhanced damages for wilful patent infringement, as Lynde Herzbach of Birch Stewart Kolasch Birch reports.   30 June 2017
Biotechnology
An advice system for labelling products in Mexico has been extended to food and non-alcoholic beverages. Daniel Sanchez and Victor Ramirez of Olivares report on how the regime works in practice.   30 June 2017
Genetics
Marisa Moura Momoli of Di Blasi, Parente & Associados looks at the fast-developing CRISPR/Cas9 technology and discusses its patentability in Brazil.   29 June 2017
Americas
Pfizer and a class of direct purchasers have each filed motions for summary judgment at a Virginia district court centring on antitrust allegations made against Pfizer.   29 June 2017
article
Two decisions in India on the protection of plant varieties provide useful guidance in this area, as Archana Shanker of Anand and Anand reports.   29 June 2017
Americas
Diagnostic company Hologic has filed a complaint against Fujifilm for allegedly infringing its patents covering a breast imaging system.   29 June 2017
Americas
The US Food and Drug Administration has revealed plans to increase competition in the US market for prescription drugs, as well as to facilitate the entry of generic drugs into the market.   28 June 2017
Americas
The US Court of Appeals for the Federal Circuit has vacated and remanded the Patent Trial and Appeal Board’s decision to invalidate a foetal testing patent.   28 June 2017
Biotechnology
The formal requirements for priority have become a hot topic at the European Patent Office, driven by their importance in high-profile oppositions to the Broad Institute’s CRISPR/Cas9 patents, as Catherine Coombes of HGF explains.   28 June 2017
Europe
Spain’s new patent law came into force on April 1, and it contains a few measures which will affect pharmaceutical companies, says Dámaso Gallardo of Clarke Modet & Co.   28 June 2017